A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.57 USD -5.38% Market Closed
Market Cap: 416.1m USD
Have any thoughts about
Aquestive Therapeutics Inc?
Write Note

Aquestive Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aquestive Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
PP&E Net
$9.4m
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
PP&E Net
$20.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Net
$8.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
PP&E Net
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
PP&E Net
$23.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
PP&E Net
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%

See Also

What is Aquestive Therapeutics Inc's PP&E Net?
PP&E Net
9.4m USD

Based on the financial report for Jun 30, 2024, Aquestive Therapeutics Inc's PP&E Net amounts to 9.4m USD.

What is Aquestive Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
-3%

Over the last year, the PP&E Net growth was -10%. The average annual PP&E Net growth rates for Aquestive Therapeutics Inc have been 2% over the past three years , -3% over the past five years .

Back to Top